Case number 1:24-cv-00268
American Regent, Inc. v. RK Pharma Inc. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 10, 2024 | 7 | NOTICE of Voluntary Dismissal by American Regent, Inc. as to Without Prejudice (Viceconte, Christopher) (Entered: 04/10/2024) (2) |
| Apr 10, 2024 | N/A | CASE CLOSED (dlw) (Entered: 04/10/2024) (0) |
| Apr 10, 2024 | 8 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s). (Attachments: # 1 Notice of Voluntary Dismissal)(mdb) (Entered: 04/10/2024) (0) |
| Mar 6, 2024 | N/A | Case Assigned to Judge Maryellen Noreika. Please include the initials of the Judge (MN) after the case number on all documents filed. (rjb) (Entered: 03/06/2024) (0) |
| Feb 29, 2024 | 1 | Complaint* (1) |
| Feb 29, 2024 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mrr) (Entered: 02/29/2024) (3) |
| Feb 29, 2024 | 3 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: January 25,2024. Date of Expiration of Patent: July 1, 2041.Thirty Month Stay Deadline: 7/25/2026. (mrr) (Entered: 02/29/2024) (1) |
| Feb 29, 2024 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 11,786,548. (mrr) (Entered: 02/29/2024) (1) |
| Feb 29, 2024 | 5 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Daiichi Sankyo Company, Limited, Corporate Parent Daiichi Sankyo, Inc., Corporate Parent Daiichi Sankyo U.S. Holdings, Inc. for American Regent, Inc. filed by American Regent, Inc. (mrr) (Entered: 03/01/2024) (2) |
| Feb 29, 2024 | 6 | Summons Issued as to Apicore US LLC on 2/29/2024; Archis Pharma LLC on 2/29/2024; RK Pharma Inc. on 2/29/2024; VGYAAN Pharmaceuticals LLC on 2/29/2024. (Attachments: # 1 Summons Issued, # 2 Summons Issued, # 3 Summons Issued)(mrr) (Entered: 03/01/2024) (0) |
